Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
NovoCure Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Duke University
National Cancer Institute (NCI)
Daiichi Sankyo
AstraZeneca
AstraZeneca
University of Kentucky
MedImmune LLC
Hoffmann-La Roche
Hackensack Meridian Health
Albert Einstein College of Medicine
Incyte Corporation
Hoffmann-La Roche
Emory University
NeoImmuneTech
M.D. Anderson Cancer Center
MedImmune LLC
Hoffmann-La Roche
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
Jiangsu HengRui Medicine Co., Ltd.
AstraZeneca
NRG Oncology
AstraZeneca
AstraZeneca
EMD Serono
AstraZeneca
Janssen Research & Development, LLC
Abramson Cancer Center at Penn Medicine
University of Nebraska
Thomas Jefferson University
City of Hope Medical Center
Merck Sharp & Dohme LLC
University of California, Irvine
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC